4
P. M. KRIŽKOVÁ ET AL.
(R)- and (S)-[16O,17O,18O]phosphoenol pyruvate by the α-
hydroxyphosphonate-phosphate rearrangement. Deprotection
by the literature protocol will afford the P-chiral phosphoenol
pyruvates. The presented sequence is a formal synthesis of (R)-
and (S)-[16O,17O,18O]phosphoenol pyruvate.
/ CH2Cl2, 5:1; TLC with heptane / CH2Cl2, 4:1; trans: Rf = 0.52,
cis: Rf = 0.38) allowed the separation of the isomers, but with
losses in yields, especially for the more polar cis-isomer.
trans-( )-7: IR (ATR): ν = 1375, 1271, 1211, 1191, 1167,
1
1105, 1020, 1003, 965 cm–1. H NMR (400.27 MHz, CDCl3):
δ = 7.39-7.28 (m, 5H), 5.51 (ddd, J = 12.0, 3.2, 2.1 Hz, 1H),
4.61 (septd, J = 6.4, 5.9 Hz, 1H), 2.20 (dd, J = 14.3, 12.0 Hz,
1H), 1.87 (ddd, J = 14.3, 3.2, 2.1 Hz, 1H), 1.64 (s, 3H), 1.35 (s,
3H). 13C NMR (150.93 MHz, CDCl3): δ = 140.7 (d, J = 3.0 Hz),
128.6 (2C), 128.2, 125.7 (2C), 121.3 (q with fine structure, J =
283.4 Hz, 2C), 78.0 (d, J = 9.1 Hz), 70.0 (septd, J = 33.4, 23.8 Hz),
68.7 (d, J = 3.0 Hz), 46.3 (d, J = 3.5 Hz), 32.5 (d, J = 4.5 Hz), 28.0.
31P NMR (162.03 MHz, CDCl3): δ = 132.0 (sept, J = 7.2 Hz).
Anal. Calcd for C14H15F6O3P (376.23): C, 44.69; H, 4.02. Found:
C, 44.78; H, 4.22.
cis-( )-7: IR (ATR): ν = 2917, 1375, 1290, 1228, 1197, 1107,
1057, 968 cm–1. 1H NMR (600.25 MHz, CD2Cl2): δ = 7.34-7.23
(m, 5H), 5.24 (td, J = 12.6, 3.3 Hz, 1H), 4.73 (septd, J = 7.4,
6.0 Hz, 1H), 2.69 (dd, J = 14.9, 12.6 Hz, 1H), 1.87 (td, J = 14.9,
3.3 Hz, 1H), 1.47 (s, 3H), 1.35 (s, 3H). 13C NMR (150.93 MHz,
CD2Cl2): δ = 141.4, 128.6 (2C), 128.1, 126.1 (2C), 121.5 (q with
fine structure, J = 284.5 Hz, 2C), 77.5 (d, J = 7.6 Hz), 74.0 (d, J
= 7.4 Hz), 70.4 (septd, J = 33.7, 27.2 Hz), 44.6 (d, J = 15.7 Hz),
31.2, 28.1 (d, J = 1.5 Hz). 31P NMR (242.99 MHz, CD2Cl2): δ =
132.3 (sept, J = 7.9 Hz).
Experimental
1H, 13C (J-modulated) and 31P NMR spectra were recorded
in CDCl3 and CD2Cl2 with a Bruker Avance AV III 400 (1H:
400.27 MHz, 13C: 100.65 MHz, 31P: 162.03 MHz) and with a
Bruker Avance AV III 600 (1H: 600.25 MHz, 13C: 150.93 MHz,
31P: 242.94 MHz) spectrometer at 25°C. Chemical shifts (δ) are
reported in parts per million (ppm) relative to CHCl3 / CDCl3
(δ 7.24, δ 77.0) and CHDCl2 / CD2Cl2 (δ 5.24, δ 53.5) and
H
C
H
C
external H3PO4 (85%; δ 0.0); coupling constants (J) are given
P
in Hz. Data for 1H NMR spectra are reported as follows: chem-
ical shift, multiplicity (s = singlet, d = doublet, t = triplet, q =
quartet, sept = septet, m = multiplet), coupling constants, and
integration. IR spectra were recorded with a Bruker VERTEX 70
IR Spectrometer in ATR mode. HPLC was performed either on
a Jasco System with a PU-980 pump, UV 975 and RI 930 detec-
tor (in case of analytical determination) or on a Dynamix Model
SD-1 with a UV-1 absorbance detector (in case of semiprepara-
tive separation using Nucleosil 50–5 column, Ø 4.6 cm × 25 cm).
Melting points were measured with a Leica Galen III Thermovar
instrument and are uncorrected. Small amounts of liquids were
added to reaction mixtures by using a μL syringe.
Test of thermal configurational stability of trans-( )-7
Flash (column) chromatography was performed with silica
gel 60 (230–400 mesh) and monitored by TLC, conducted on
glass-backed 0.25 mm thick silica gel 60 F254. Spots were visu-
alized by UV and / or dipping the plate into a solution of
(NH4)6Mo7O24 • 4 H2O (23.0 g) and Ce(SO4)2 • 4 H2O (1.0 g)
in 10% aqueous H2SO4 (500 mL), followed by heating with a
heat gun.
A small sample (50 mg) of trans-( )-7 was bulb to bulb distilled
1
(80°C / 1 mbar). The H and 31P NMR spectrum recorded in
toluene-d8 showed that the distilled sample was still homoge-
neous and did not contain cis-( )-7.
Hydrolysis of cyclic phosphites ( )-7 – cis- and trans-( )-
4,4-dimethyl-6-phenyl-1,3,2-dioxaphosphinane-2-oxides
[cis- and trans-( )-4]
cis- and trans-( )-2-[(1,1,1,3,3,3-Hexafluoropropan-2-
yl)oxy]-4,4-dimethyl-6-phenyl-1,3,2-dioxaphosphinane
[cis- and trans-( )-7]
A mixture of phosphites cis- and trans-( )-7 (0.75 g, 2.0 mmol,
A mixture of diol ( )-2 (0.36 g, 2 mmol), tris(1,1,1,3,3,3- trans/cis, 2:1), H2O (7.2 mmol, 0.13 mL) and TMSCl (0.11 g,
hexafluoro-2-propyl) phosphite[13] (1.117 g, 2.1 mmol, sensi- 1.0 mmol, 0.12 mL) in dry THF (5 mL) was stirred at
tive to oxygen and moisture!) and Et3N (1 mmol, 0.14 mL) room temperature under argon for 30 min. 1,1,1,3,3,3-
in dry CH2Cl2 (8 mL) was stirred under argon for 40 min at Hexamethyldisilazane (0.18 g, 1.1 mmol, 0.14 mL) was added
room temperature and then concentrated under reduced pres- (under argon!) and the solution was concentrated under
sure (trans/cis, 2:1, by 31P NMR). The crude product was puri- reduced pressure. The crude product was dried (45°C / 1 mbar)
fied by bulb to bulb distillation (65–100°C / 1.4 mbar) to yield a for 5 min and then purified by flash chromatography (EtOAc,
mixture of cyclic phosphites trans- and cis-( )-7 (0.669 g, 89%) Rf = 0.50) to yield a crystalline mixture (0.31 g, 69%; cis/trans,
1
as a colorless oil. The isomers were separated by semiprepara- 2.5:1 by H NMR) of cyclic H-phosphonates cis- and trans-4.
tive HPLC; injection of 1.8 mL of solution (25 mg of mixture The NMR spectra (1H, 31P) were identical to those of the
of cis/trans-( )-7/mL); 10% CH2Cl2 in hexanes (40 mL/min); literature.[8]
trans-( )-7: tr = 2.32 min, mp 37–38°C (hexanes); cis-( )-7: tr
Similarly, phosphite cis-( )-7 (0.15 g, 0.40 mmol) was con-
verted to H-phosphonate trans-( )-4 [0.07 g, 78%, contained
= 2.77 min, colorless oil.
Alternatively, a rapid flash chromatography (heptane / 10% of cis-( )-4] as colorless solid.
EtOAc, 7:1, trans: Rf = 0.69, cis: Rf = 0.58) gave a mixture with
Similarly, phosphite trans-( )-3 (0.42 g, 1.12 mmol) was
the same ratio of the isomers as in the crude product with mini- converted to H-phosphonate cis-( )-4 [0.23 g, 91%, contained
mal loss of product. A standard flash chromatography (heptane 6% of trans-( )-4] as colorless solid.